Vu Quynh Ngoc, Young Reginald, Sudhakar Haritha Krishna, Gao Tianyi, Huang Tiancheng, Tan Yaw Sing, Lau Yu Heng
School of Chemistry, Eastern Ave, The University of Sydney NSW 2006 Australia
Bioinformatics Institute, Agency for Science, Technology and Research (ASTAR) 30 Biopolis Street, #07-01, Matrix Singapore 138671 Singapore.
RSC Med Chem. 2021 Apr 28;12(6):887-901. doi: 10.1039/d1md00098e. eCollection 2021 Jun 23.
Cyclisation is a common synthetic strategy for enhancing the therapeutic potential of peptide-based molecules. While there are extensive studies on peptide cyclisation for reinforcing regular secondary structures such as α-helices and β-sheets, there are remarkably few reports of cyclising peptides which adopt irregular conformations in their bioactive target-bound state. In this review, we highlight examples where cyclisation techniques have been successful in stabilising irregular conformations, then discuss how the design of cyclic constraints for irregularly structured peptides can be informed by existing β-strand stabilisation approaches, new computational design techniques, and structural principles extracted from cyclic peptide library screening hits. Through this analysis, we demonstrate how existing peptide cyclisation techniques can be adapted to address the synthetic design challenge of stabilising irregularly structured binding motifs.
环化是增强基于肽的分子治疗潜力的一种常见合成策略。虽然关于肽环化以增强规则二级结构(如α-螺旋和β-折叠)已有广泛研究,但对于在其生物活性靶点结合状态下采用不规则构象的肽进行环化的报道却非常少。在本综述中,我们重点介绍了环化技术成功稳定不规则构象的实例,然后讨论如何通过现有的β-链稳定方法、新的计算设计技术以及从环肽库筛选命中物中提取的结构原理,来为不规则结构肽的环化约束设计提供依据。通过这一分析,我们展示了如何调整现有的肽环化技术,以应对稳定不规则结构结合基序的合成设计挑战。